Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Zhen He, Lei Dai, Yuyue Zuo, Yu Chen, Hongjie Wang & Hesong Zeng. (2022) Hotspots and frontiers in pulmonary arterial hypertension research: a bibliometric and visualization analysis from 2011 to 2020. Bioengineered 13:6, pages 14667-14680.
Read now
Read now
Yong Lv, Guohong Han & Daiming Fan. (2016) Portopulmonary hypertension. Scandinavian Journal of Gastroenterology 51:7, pages 795-806.
Read now
Read now
Peter Norman. (2015) Evaluation of US20150011555. An inhaled IP receptor agonist for the treatment of pulmonary arterial hypertension. Expert Opinion on Therapeutic Patents 25:8, pages 939-944.
Read now
Read now
Mitchell S Buckley, Andrew J Berry, Nadine H Kazem, Shardool A Patel & Paul A Librodo. (2014) Clinical utility of treprostinil in the treatment of pulmonary arterial hypertension: an evidence-based review. Core Evidence 9, pages 71-80.
Read now
Read now
Articles from other publishers (19)
Taro Yasuma, Hajime Fujimoto, Corina N. D’Alessandro-Gabazza, Esteban C. Gabazza, Osamu Hataji & Tetsu Kobayashi. (2023) Epoprostenol and Treprostinil: Differential Effects on Regulatory T-Cell Generation in Patients with Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine 208:11, pages 1248-1248.
Crossref
Crossref
Aneesh A Bang, Sonali Bang, Arun Bang, Sourya Acharya & Samarth Shukla. (2023) Recent Advances in the Treatment of Interstitial Lung Diseases. Cureus.
Crossref
Crossref
Felix R. De Bie, Catherine M. Avitabile, Sabrina Flohr, Sierra Land, Leny Mathew, Yan Wang, Devon Ash, Natalie E. Rintoul & Holly L. Hedrick. (2023) Treprostinil in Neonates with Congenital Diaphragmatic Hernia-Related Pulmonary Hypertension. The Journal of Pediatrics, pages 113420.
Crossref
Crossref
Gonzalo Gonzalo & Andrés R. Alcántara. 2022. Catalytic Asymmetric Synthesis. Catalytic Asymmetric Synthesis
531
558
.
Nicholas S. Hill, Jeremy P. Feldman, Sandeep Sahay, Raymond L. Benza, Ioana R. Preston, David Badesch, Robert P. Frantz, Savan Patel, Ashley Galloway & Todd M. Bull. (2022) INSPIRE: Safety and tolerability of inhaled Yutrepia (treprostinil) in pulmonary arterial hypertension (PAH). Pulmonary Circulation 12:3.
Crossref
Crossref
S.K. Katiyar, S.N. Gaur, R.N. Solanki, Nikhil Sarangdhar, J.C. Suri, Raj Kumar, G.C. Khilnani, Dhruva Chaudhary, Rupak Singla, Parvaiz A. Koul, Ashok A. Mahashur, A.G. Ghoshal, D. Behera, D.J. Christopher, Deepak Talwar, Dhiman Ganguly, H. Paramesh, K.B. Gupta, Mohan Kumar T, P.D. Motiani, P.S. Shankar, Rajesh Chawla, Randeep Guleria, S.K. Jindal, S.K. Luhadia, V.K. Arora, V.K. Vijayan, Abhishek Faye, Aditya Jindal, Amit K. Murar, Anand Jaiswal, Arunachalam M, A.K. Janmeja, Brijesh Prajapat, C. Ravindran, Debajyoti Bhattacharyya, George D'Souza, Inderpaul Singh Sehgal, J.K. Samaria, Jogesh Sarma, Lalit Singh, M.K. Sen, Mahendra K. Bainara, Mansi Gupta, Nilkanth T. Awad, Narayan Mishra, Naveed N. Shah, Neetu Jain, Prasanta R. Mohapatra, Parul Mrigpuri, Pawan Tiwari, R. Narasimhan, R. Vijai Kumar, Rajendra Prasad, Rajesh Swarnakar, Rakesh K. Chawla, Rohit Kumar, S. Chakrabarti, Sandeep Katiyar, Saurabh Mittal, Sonam Spalgais, Subhadeep Saha, Surya Kant, V.K. Singh, Vijay Hadda, Vikas Kumar, Virendra Singh, Vishal Chopra & Visweswaran B. (2022) Indian Guidelines on Nebulization Therapy. Indian Journal of Tuberculosis 69, pages S1-S191.
Crossref
Crossref
Shu-Ting Huang, Ning Xu, Kai-Peng Sun, Qiang Chen & Hua Cao. (2021) Effect of Treprostinil on the Early Postoperative Prognosis of Patients with Severe Left Heart Valvular Disease Combined with Severe Pulmonary Hypertension. Annals of Thoracic and Cardiovascular Surgery 27:1, pages 18-24.
Crossref
Crossref
Shu-Ting Huang, Ning Xu, Kai-Peng Sun, Liang-Wan Chen, Hua Cao & Qiang Chen. (2020) The Effect of Perioperative Administration of Treprostinil in Infants with Non-restrictive Ventricular Septal Defect and Severe Pulmonary Arterial Hypertension. Pediatric Cardiology 41:7, pages 1334-1339.
Crossref
Crossref
Laura Malinauskiene, Goda Šlekyte, Martin Mowitz, Marléne Isaksson & Rolandas Zablockis. (2020) Allergic contact dermatitis caused by isobornyl acrylate in two patients treated for idiopathic pulmonary arterial hypertension. Contact Dermatitis 83:2, pages 170-171.
Crossref
Crossref
Sean AinsworthSean Ainsworth. 2020. Neonatal Formulary. Neonatal Formulary
275
307
.
Mia Lindegaard Pedersen, Marcus Krüger, Daniela Grimm, Manfred Infanger & Markus Wehland. (2019) The prostacyclin analogue treprostinil in the treatment of pulmonary arterial hypertension. Basic & Clinical Pharmacology & Toxicology 126:1, pages 32-42.
Crossref
Crossref
Christina Picken, Peter Laing, Lei Shen, Lucie H. Clapp & Steve Brocchini. (2020) Synthetic routes to treprostinil N-acyl methylsulfonamide. Tetrahedron Letters 61:5, pages 151428.
Crossref
Crossref
Tengke Wang, Jiakai Lu, Qiang Li, Yao Chen, Qing Ye, Jie Gao, Dong Yang, Liyun Zhao, Jiapeng HuangJinglan Zhang. (2019) Rapid Titration of Intravenous Treprostinil to Treat Severe Pulmonary Arterial Hypertension Postpartum: A Retrospective Observational Case Series Study. Anesthesia & Analgesia 129:6, pages 1607-1612.
Crossref
Crossref
Pablo de María, Gonzalo de Gonzalo & Andrés Alcántara. (2019) Biocatalysis as Useful Tool in Asymmetric Synthesis: An Assessment of Recently Granted Patents (2014–2019). Catalysts 9:10, pages 802.
Crossref
Crossref
Keith R. Hildebrand. 2015. Drug-Device Combinations For Chronic Diseases. Drug-Device Combinations For Chronic Diseases
182
213
.
Pat MetharomMichael C. BerndtRoss I. BakerRobert K. Andrews. (2015) Current State and Novel Approaches of Antiplatelet Therapy. Arteriosclerosis, Thrombosis, and Vascular Biology 35:6, pages 1327-1338.
Crossref
Crossref
Amanda Jones, Laurene Wang-Smith, Theresa Pham & Kevin Laliberte. (2014) Pharmacokinetics of 3 Times a Day Dosing of Oral Treprostinil in Healthy Volunteers. Journal of Cardiovascular Pharmacology 63:3, pages 227-232.
Crossref
Crossref
Shirin Bruderer, Noémie Hurst, Priska Kaufmann & Jasper Dingemanse. (2014) Multiple-Dose Up-Titration Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Selexipag, an Orally Available Selective Prostacyclin Receptor Agonist, in Healthy Subjects. Pharmacology 94:3-4, pages 148-156.
Crossref
Crossref
Yan Wu, Dermot S. O’Callaghan & Marc Humbert. (2013) An Update on Medical Therapy for Pulmonary Arterial Hypertension. Current Hypertension Reports 15:6, pages 614-622.
Crossref
Crossref